Antiendotoxin strategies

被引:30
作者
Hellman, J
Warren, HS
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA
关键词
D O I
10.1016/S0891-5520(05)70080-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Endotoxin is a potent stimulator of the inflammatory response and is believed to initiate the pathology in Gram-negative sepsis. Agents are being developed that bind and neutralize or block the effects of endotoxin, with the goal of improving outcome in the treatment of sepsis. Strategies discussed in this article include anti-LPS antibodies, LPS binding proteins and lipoproteins, poly myxin B conjugates, Lipid A analogues, and extracorporeal techniques for endotoxin removal.
引用
收藏
页码:371 / +
页数:17
相关论文
共 158 条
[1]  
Abrahamson SL, 1997, J BIOL CHEM, V272, P2149
[2]   FALL-39, A PUTATIVE HUMAN PEPTIDE ANTIBIOTIC, IS CYSTEINE-FREE AND EXPRESSED IN BONE-MARROW AND TESTIS [J].
AGERBERTH, B ;
GUNNE, H ;
ODEBERG, J ;
KOGNER, P ;
BOMAN, HG ;
GUDMUNDSSON, GH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) :195-199
[3]   An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma [J].
Aida, Y ;
Kusumoto, K ;
Nakatomi, K ;
Takada, H ;
Pabst, MJ ;
Maeda, K .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (06) :675-682
[4]   LIMULUS ANTILIPOPOLYSACCHARIDE FACTOR PROTECTS RABBITS FROM MENINGOCOCCAL ENDOTOXIN-SHOCK [J].
ALPERT, G ;
BALDWIN, G ;
THOMPSON, C ;
WAINWRIGHT, N ;
NOVITSKY, TJ ;
GILLIS, Z ;
PARSONNET, J ;
FLEISHER, GR ;
SIBER, GR .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :494-500
[5]  
AMMONS WS, 1993, CIRC SHOCK, V41, P176
[6]   TREATMENT OF SEPSIS BY EXTRACORPOREAL ELIMINATION OF ENDOTOXIN USING POLYMYXIN B-IMMOBILIZED FIBER [J].
AOKI, H ;
KODAMA, M ;
TANI, T ;
HANASAWA, K .
AMERICAN JOURNAL OF SURGERY, 1994, 167 (04) :412-417
[7]  
ASTIZ ME, 1993, CIRC SHOCK, V39, P194
[8]   PRETREATMENT OF NORMAL HUMANS WITH MONOPHOSPHORYL LIPID-A INDUCES TOLERANCE TO ENDOTOXIN - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL [J].
ASTIZ, ME ;
RACKOW, EC ;
STILL, JG ;
HOWELL, ST ;
CATO, A ;
VONESCHEN, KB ;
ULRICH, JT ;
RUDBACH, JA ;
MCMAHON, G ;
VARGAS, R ;
STERN, W .
CRITICAL CARE MEDICINE, 1995, 23 (01) :9-17
[9]   A phase I safety and pharmacokinetic study of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in healthy male volunteers [J].
Bauer, RJ ;
White, ML ;
Wedel, N ;
Nelson, BJ ;
Friedmann, N ;
Cohen, A ;
Hustinx, WNM ;
Kung, AHC .
SHOCK, 1996, 5 (02) :91-96
[10]   Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution [J].
Beamer, LJ ;
Carroll, SF ;
Eisenberg, D .
SCIENCE, 1997, 276 (5320) :1861-1864